Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D and Lasting Gene Regulation: Study Summary

Previous related pageVitamin D and Lasting Gene Regulation: Full Evidence ReviewNext related pageVitamin D and Lasting Gene Regulation: Full Evidence Review
Study at a glance

What question did the studies ask?

Researchers asked whether vitamin D-related changes in gene regulation can last after the original exposure changes. A response during continuing treatment is different from a response that remains after treatment ends. DNA carries genetic information. A chemical mark on DNA is different from a change in gene activity.

What did the researchers find?

In one mouse study, cells from fetal liver were transferred into other mice with sufficient vitamin D. Some later gene-activity patterns and altered responses to insulin persisted. Insulin is a hormone that helps regulate blood sugar. The experiment did not isolate the DNA marks as the sole cause. Another mouse study found variable DNA marks in later generations, without a clear overall change in the measured neonatal gene expression. The mother mice ate a vitamin D-depleted diet. Their developing offspring included cells that later produced sperm, so those cells were directly exposed too.

Human pregnancy studies measured DNA marks at birth. They did not establish lasting changes in children’s gene activity. A year-long randomized vitamin D3 trial did not find a clear whole-blood gene-expression response under its analysis. That does not rule out responses in other tissues or at earlier times.

What does this mean?

Human biological-age scores gave mixed findings. The larger three-year trial did not show a clear vitamin D-alone effect on its four scores. These scores do not measure lifespan or persistent gene regulation after withdrawal. The evidence supports selected animal programming mechanisms, but does not establish lasting beneficial gene reprogramming in people.

Read the full article below ↓

Some mouse experiments show gene-regulatory changes that remain after the original vitamin D environment changes. Human studies have not established the same lasting effect: a DNA mark at birth, a calculated age score and a gene-activity test during continuing treatment measure different things. For the detailed evidence, read Vitamin D and Lasting Gene Regulation: Full Evidence Review.

What would a lasting effect mean?

DNA carries genetic information. Chemical marks on it can be studied without changing its underlying sequence. A mark and a change in gene activity are different results. Vitamin D and Epigenetic Regulation explains DNA-related regulation, and Vitamin D and Gene Expression explains gene activity.

A response during continuing treatment does not show that the response remains after treatment ends. A later generation can also have been exposed indirectly during development. These distinctions matter when judging claims of biological memory or inheritance.

What did the mouse studies show?

Oh and colleagues collected a mixture of liver cells from unborn mouse offspring. Their mothers had received vitamin D-deficient or sufficient diets. The cells were transferred into other mice with sufficient vitamin D. The cells included blood-forming stem cells; they were not purified stem-cell transfers. Some later gene-activity patterns and altered responses to insulin remained for months and through a second transfer. Insulin is a hormone that helps regulate blood sugar. This is stronger persistence evidence than one measurement during continuing deficiency. [1]

The researchers measured DNA methylation, a type of chemical marking on DNA. Selected marks near Jarid2 were higher, and there was less RNA from the Jarid2 gene. RNA is a message copied from an active gene. This did not directly measure the regulator protein’s activity. But the researchers did not selectively change those marks to prove they alone caused the persistent programme. Human mother: cord observations in the same paper were not a follow-up of diabetes in children. The metabolic question relates to Vitamin D and Insulin Signalling. [1]

Xue and colleagues found variable DNA marks across mouse generations, depending on tissue, sex and strain. They did not detect a significant overall dietary effect on the tested genes’ total expression in second-generation newborn liver. Mother mice had received a vitamin D-depleted diet. Their developing offspring included cells that later produced sperm, so those cells had been directly exposed too. This was not proof of an unchanged mark inherited through a wholly unexposed generation. [2]

What did the human studies establish?

MAVIDOS compared vitamin D3 with placebo during pregnancy. A placebo is an inactive comparison treatment. Small DNA-mark differences were reported in cord tissue, but overall adjusted findings did not establish a clear result after accounting for the number of sites tested. One sample at birth did not show persistence, later gene activity or a health benefit in the children. [3]

A larger observational newborn study found no clear DNA-site associations after accounting for many tests. It limits a broad newborn signature without excluding every possible tissue or exposure window. This was not a randomized test of lasting gene control. [4]

BEST-D randomized 305 older adults to 2,000 or 4,000 international units of vitamin D3 daily or placebo for a year. Despite higher vitamin D levels with treatment, the controlled whole-blood RNA analysis did not find genes meeting its standard for a clear response after accounting for many tests. RNA is the message copied from an active gene. This does not exclude earlier responses or effects in other cells. Continuing treatment for a year also did not test persistence after withdrawal. Vitamin D Status vs Vitamin D Effect explains why status and biological effect are different. [5]

Human biological-age scores gave mixed results. The larger three-year DO-HEALTH analysis did not show a clear vitamin D-alone effect on four scores. Omega-3 or combination findings cannot be assigned to vitamin D alone. Smaller or observational reports found some positive results, but none demonstrated specific gene regulation lasting after treatment stopped. [6] [7] [8]

What is the practical scientific conclusion?

Selected mouse experiments support persistent programming, with incomplete proof that particular DNA marks caused it. DNA marks measured at birth, age scores and late blood gene activity do not establish lasting beneficial reprogramming in people. These studies do not provide personal treatment instructions or a dose for creating biological memory.

Scientific sources

[1] Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Oh J, Riek AE, Bauerle KT, Dusso A, McNerney KP, Barve RA, Darwech I, Sprague JE, Moynihan C, Zhang RM, Kutz G, Wang T, Xing X, Li D, Mrad M, Wigge NM, Castelblanco E, Collin A, Bambouskova M, Head RD, Sands MS, Bernal-Mizrachi C. Nature communications. 2023;14(1):3278. DOI 10.1038/s41467-023-38849-z; PMID 37311757; PMCID PMC10264405.

[2] Maternal vitamin D depletion alters DNA methylation at imprinted loci in multiple generations. Xue J, Schoenrock SA, Valdar W, Tarantino LM, Ideraabdullah FY. Clinical epigenetics. 2016;8:107. DOI 10.1186/s13148-016-0276-4; PMID 27777636; PMCID PMC5062906.

[3] Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial. Curtis EM, Krstic N, Cook E, D’Angelo S, Crozier SR, Moon RJ, Murray R, Garratt E, Costello P, Cleal J, Ashley B, Bishop NJ, Kennedy S, Papageorghiou AT, Schoenmakers I, Fraser R, Gandhi SV, Prentice A, Javaid MK, Inskip HM, Godfrey KM, Bell CG, Lillycrop KA, Cooper C, Harvey NC, MAVIDOS Trial Group. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2019;34(2):231-240. DOI 10.1002/jbmr.3603; PMID 30321476; PMCID PMC6372078.

[4] Epigenome-wide meta-analysis of prenatal vitamin D insufficiency and cord blood DNA methylation. Diemer EW, Tuhkanen J, Sammallahti S, Heinonen K, Neumann A, Robinson SL, Suderman M, Jin J, Page CM, Fore R, Rifas-Shiman SL, Oken E, Perron P, Bouchard L, Hivert MF, Räikköne K, Lahti J, Yeung EH, Guan W, Mumford SL, Magnus MC, Håberg S, Nystad W, Parr CL, London SJ, Felix JF, Tiemeier H. Epigenetics. 2024;19(1):2413815. DOI 10.1080/15592294.2024.2413815; PMID 39418282; PMCID PMC11487971.

[5] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, Heger A, Emberson J, Armitage J, Clarke R, Knight JC. EBioMedicine. 2018;31:133-142. DOI 10.1016/j.ebiom.2018.04.010; PMID 29685792; PMCID PMC6013786.

[6] Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Bischoff-Ferrari HA, Gängler S, Wieczorek M, Belsky DW, Ryan J, Kressig RW, Stähelin HB, Theiler R, Dawson-Hughes B, Rizzoli R, Vellas B, Rouch L, Guyonnet S, Egli A, Orav EJ, Willett W, Horvath S. Nature aging. 2025;5(3):376-385. DOI 10.1038/s43587-024-00793-y; PMID 39900648; PMCID PMC11922767.

[7] Vitamin D supplementation is associated with slower epigenetic aging. Vetter VM, Sommerer Y, Kalies CH, Spira D, Bertram L, Demuth I. GeroScience. 2022;44(3):1847-1859. DOI 10.1007/s11357-022-00581-9; PMID 35562603; PMCID PMC9213628.

[8] Effects of Vitamin D3 Supplementation on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D Status: A Randomized Clinical Trial. Chen L, Dong Y, Bhagatwala J, Raed A, Huang Y, Zhu H. The journals of gerontology. Series A, Biological sciences and medical sciences. 2019;74(1):91-98. DOI 10.1093/gerona/gly223; PMID 30256915; PMCID PMC6612014.

Related reading

Original sources

Source

Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes

Environmental factors may alter the fetal genome to cause metabolic diseases.

Publication details

[1] Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Oh J, Riek AE, Bauerle KT, Dusso A, McNerney KP, Barve RA, Darwech I, Sprague JE, Moynihan C, Zhang RM, Kutz G, Wang T, Xing X, Li D, Mrad M, Wigge NM, Castelblanco E, Collin A, Bambouskova M, Head RD, Sands MS, Bernal-Mizrachi C. Nature communications. 2023;14(1):3278. DOI 10.1038/s41467-023-38849-z; PMID 37311757; PMCID PMC10264405.

Read more →
Source

Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial

In this study, we used an existing randomized trial to test the hypothesis that maternal gestational vitamin D supplementation would lead to reduced perinatal RXRA locus DNA methylation.

Publication details

[3] Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial. Curtis EM, Krstic N, Cook E, D’Angelo S, Crozier SR, Moon RJ, Murray R, Garratt E, Costello P, Cleal J, Ashley B, Bishop NJ, Kennedy S, Papageorghiou AT, Schoenmakers I, Fraser R, Gandhi SV, Prentice A, Javaid MK, Inskip HM, Godfrey KM, Bell CG, Lillycrop KA, Cooper C, Harvey NC, MAVIDOS Trial Group. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2019;34(2):231-240. DOI 10.1002/jbmr.3603; PMID 30321476; PMCID PMC6372078.

Read more →
Source

Epigenome-wide meta-analysis of prenatal vitamin D insufficiency and cord blood DNA methylation

We aimed to evaluate whether maternal vitamin D insufficiency during pregnancy was conditionally associated with DNA methylation in the offspring cord blood.

Publication details

[4] Epigenome-wide meta-analysis of prenatal vitamin D insufficiency and cord blood DNA methylation. Diemer EW, Tuhkanen J, Sammallahti S, Heinonen K, Neumann A, Robinson SL, Suderman M, Jin J, Page CM, Fore R, Rifas-Shiman SL, Oken E, Perron P, Bouchard L, Hivert MF, Räikköne K, Lahti J, Yeung EH, Guan W, Mumford SL, Magnus MC, Håberg S, Nystad W, Parr CL, London SJ, Felix JF, Tiemeier H. Epigenetics. 2024;19(1):2413815. DOI 10.1080/15592294.2024.2413815; PMID 39418282; PMCID PMC11487971.

Read more →
Source

Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.

[5] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.

Publication details

[5] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, Heger A, Emberson J, Armitage J, Clarke R, Knight JC. EBioMedicine. 2018;31:133-142. DOI 10.1016/j.ebiom.2018.04.010; PMID 29685792; PMCID PMC6013786.

Read more →
Source

Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial.

[6] Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial.

Publication details

[6] Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Bischoff-Ferrari HA, Gängler S, Wieczorek M, Belsky DW, Ryan J, Kressig RW, Stähelin HB, Theiler R, Dawson-Hughes B, Rizzoli R, Vellas B, Rouch L, Guyonnet S, Egli A, Orav EJ, Willett W, Horvath S. Nature aging. 2025;5(3):376-385. DOI 10.1038/s43587-024-00793-y; PMID 39900648; PMCID PMC11922767.

Read more →
Source

Vitamin D supplementation is associated with slower epigenetic aging

We previously reported on an association between vitamin D deficiency and higher 7-CpG DNAmAA in participants of the Berlin Aging Study II (BASE-II).

Publication details

[7] Vitamin D supplementation is associated with slower epigenetic aging. Vetter VM, Sommerer Y, Kalies CH, Spira D, Bertram L, Demuth I. GeroScience. 2022;44(3):1847-1859. DOI 10.1007/s11357-022-00581-9; PMID 35562603; PMCID PMC9213628.

Read more →
Source

Effects of Vitamin D3 Supplementation on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D Status: A Randomized Clinical Trial.

[8] Effects of Vitamin D3 Supplementation on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D Status: A Randomized Clinical Trial.

Publication details

[8] Effects of Vitamin D3 Supplementation on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D Status: A Randomized Clinical Trial. Chen L, Dong Y, Bhagatwala J, Raed A, Huang Y, Zhu H. The journals of gerontology. Series A, Biological sciences and medical sciences. 2019;74(1):91-98. DOI 10.1093/gerona/gly223; PMID 30256915; PMCID PMC6612014.

Read more →